Episode 12: Janssen's stepwise approach to AQbD and vaccine development

Update: 2021-04-22

Description

Waters welcomes back Dr. Ewoud van Tricht where he builds on the last episode when he discussed how Janssen approaches vaccine development with analytical quality by design (AQbD). Today, he elaborates on the specific steps of AQbD and the advantages gained.

Comments

In Channel

Episode 14: Harness the Power of QbD Principles

2021-09-2330:59

Episode 13: Components of a Successful AQbD Workflow

2021-06-0433:06

Episode 12: Janssen's stepwise approach to AQbD and vaccine development

2021-04-2220:24

Episode 11: Applying AQbD Principles to Vaccine Development

2021-03-2914:56

Episode 10: The Nitrosamine Crisis: Controlling Risk by Leveraging MLCM Principles - Part 3

2020-06-0319:27

Episode 9: The Nitrosamine Crisis: Controlling Risk by Leveraging MLCM Principles - Part 2

2020-05-1826:08

Episode 8: The Nitrosamine Crisis: Controlling Risk by Leveraging MLCM Principles – Part 1

2020-04-2333:13

Episode 7: Data-driven Modeling Approaches to Improve Method Development

2020-03-2727:27

Episode 6: A History of MLCM and How it Will Evolve

2019-11-0541:43

Episode 5: Benefits of Applying Analytical Quality by Design to Enhance Analytical Controls

2019-10-0139:45

Episode 4: Guidance initiatives from the USP and ICH on Method Lifecycle Management

2019-08-1438:48

Episode 3: Verification and transfer of compendial methods

2019-07-0127:04

Episode 2: Mitigating risk and improving drug quality with MLCM

2019-06-1124:43

Episode 1: Advantages of MLCM over traditional approaches

2019-05-0848:19

Trailer: Method Lifecycle Management Podcast

2019-04-1801:05

00:00

Episode 12: Janssen's stepwise approach to AQbD and vaccine development

#box-pro-ellipsis-176126129063987{-webkit-line-clamp:2;}Episode 12: Janssen's stepwise approach to AQbD and vaccine development

Episode 12: Janssen's stepwise approach to AQbD and vaccine development

Episode 12: Janssen's stepwise approach to AQbD and vaccine development